Biomarkers and Clinical Features of Metastatic Breast Cancer in Patients Treated With CDK4/6 Inhibitors

Clinical trial NCT04526587 · RECRUITING

Trial details

NCT number: NCT04526587
Sponsor: Roswell Park Cancer Institute
Status: RECRUITING
Study type: OBSERVATIONAL

Anatomic Stage IV Breast Cancer AJCC v8 Metastatic Breast Carcinoma Prognostic Stage IV Breast Cancer AJCC v8

Start date: 2020-07-03
Primary completion: 2030-07-03
Enrollment: 700

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.